telehealth glp-1 prescription florida 7 Platforms Changing How We Access GLP-1s 16 Best Places to Get

Blood, 109 (4), 14221432

The SURMOUNT-4 trial (Aronne 2023, JAMA) showed that adults who stopped tirzepatide after 36 weeks regained an average of 14.0% of body weight over the next 52 weeks, while those who continued tirzepatide lost an additional 5.5% a 19.4% between-group difference

The Rise of GLP-1 Weight Loss Injections In 2024, the percentage of overweight or obese adults prescribed GLP-1 medications increased almost sevenfold compared to 2019

Patients taking both semaglutide and thyroid medication should undergo regular thyroid function monitoring, following established guidelines for thyroid disease management